Clinical Trials Browser

Phase NA × Non-squamous Non-small Cell Lung Cancer × Gefitinib × Clear all

NCT03602027 2018-07-26

Phase I Study of the Combination of Anlotinib With Gefitinib

Phase NA Unknown

Non-squamous Non-small Cell Lung Cancer